UK Markets closed

Global Online Event Ticketing Market to Reach $61.7 Billion by 2027

ReportLinker
·27-min read

Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 8. - Influencer Pool: 442. - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies.

New York, March 30, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Empty Capsules Industry" - https://www.reportlinker.com/p06041104/?utm_source=GNW
In addition to being a global intelligence exchange platform, MarketGlass™ is a powerful knowledge center that delivers dynamic project-focused market intelligence. Client companies will have complete insider access to the project Data stack.
- Interactive peer-to-peer and enterprise-to-enterprise ideation and market intelligence exchange is facilitated via a robust, secure, and validated process. The process draws from uniquely qualified project-specific and geographically focused executives overseeing business development, marketing and sales operations.

  • Trends & Factors - Identifying and validating local trends and factors driving each competitive marketplace. These factors include pricing variances, market trajectories, Covid-19 impact and recovery, locally active leading brands, and other parameters impacting the region in the short to medium term such as supply chain realignments.

  • Mobile Access & App - Our mobile version of the report may be accessed via our mobile app or directly for a full mobile experience.

  • Complimentary Updates - for one year. At least one update in 12-month period is normal and anytime there’s a significant change affecting the market dynamics.

  • Bespoke Updates & Team Collaborations - Clients may build a bespoke version of our report with peers on our MarketGlass™ platform which enables multidimensional data simulations.

  • Knowledge Center - clients have full-stack data access for project data they support or purchase including primary research engagement stats, companies and executives.

Abstract:
- Global Empty Capsules Market to Reach $2.7 Billion by 2027
- Amid the COVID-19 crisis, the global market for Empty Capsules estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$2.7 Billion by 2027, growing at aCAGR of 5.8% over the period 2020-2027. Gelatin, one of the segments analyzed in the report, is projected to record 5.9% CAGR and reach US$2.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Non-Gelatin segment is readjusted to a revised 5.4% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $530.7 Million, While China is Forecast to Grow at 5.4% CAGR
- The Empty Capsules market in the U.S. is estimated at US$530.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$469.3 Million by the year 2027 trailing a CAGR of 5.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.5% and 4.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

- Select Competitors (Total 44 Featured) -

  • ACG Worldwide Pvt., Ltd.

  • Bright Pharmacaps Inc.

  • Capscanada Corporation

  • Capsugel, Inc.

  • Healthcaps India Limited

  • Medi-Caps Ltd.

  • Natural Capsules Ltd.

  • Nectar Lifesciences Ltd.

  • Qingdao Yiqing Medicinal Capsules Co., Ltd.

  • Qualicaps, Inc.

  • Roxlor, LLC

  • Snail Pharma Industry Co., Ltd.

  • Suheung Co Ltd.

  • Sunil Healthcare




Read the full report: https://www.reportlinker.com/p06041104/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
Empty Capsules Market to Register Steady Growth
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS
Competition
EXHIBIT 1: Market Share of Leading Players by Product Sales: 2018

3. MARKET TRENDS & DRIVERS
Rapid Growth in Ageing Population Drives Market Growth
EXHIBIT 2: Global Population Statistics and Estimates for the
60+ Age Group (1990, 2015, 2050E, 2100E)
Growth in Pharmaceutical Market to Spur Demand
EXHIBIT 3: Worldwide Pharmaceutical Market Growth by region:
2017 and 2022E
Growth in Pharmaceutical R&D and Clinical Trials to Support
Market Demand
EXHIBIT 4: Expenditure (in Billion USD) of Pharmaceutical R&D
in the US: 1980-2017)
EXHIBIT 5: Total Registered Studies Number: 2000-2021
With Increase in Technological Advancements of Drug Delivery
Systems, the Market is expected to Register Gains
Increasing Importance for Sports Nutrition to Bolster Market
Growth
EXHIBIT 6: Global Market Value (in Billion USD) of Sports
Nutrition: 2014-2024
EXHIBIT 7: Total Market Value (in Billion USD) of Sports
Nutrition in North America: 2011-2021E
Growing Application of Empty Capsules in Cosmetics and
Nutraceutical Industries to Bolster Demand

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Empty Capsules by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 2: World Historic Review for Empty Capsules by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Empty Capsules by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Gelatin by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Gelatin by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Gelatin by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 7: World Current & Future Analysis for Non-Gelatin by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 8: World Historic Review for Non-Gelatin by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Non-Gelatin by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Immediate-Release
Capsules by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 11: World Historic Review for Immediate-Release Capsules
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Immediate-Release
Capsules by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Sustained-Release
Capsules by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 14: World Historic Review for Sustained-Release Capsules
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Sustained-Release
Capsules by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Delayed-Release
Capsules by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 17: World Historic Review for Delayed-Release Capsules by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Delayed-Release
Capsules by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Antibiotics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 20: World Historic Review for Antibiotics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Antibiotics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Vitamins and
Dietary Supplements by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 23: World Historic Review for Vitamins and Dietary
Supplements by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 24: World 15-Year Perspective for Vitamins and Dietary
Supplements by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Antacid &
Antiflatulent Preparations by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 26: World Historic Review for Antacid & Antiflatulent
Preparations by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 27: World 15-Year Perspective for Antacid & Antiflatulent
Preparations by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR

Table 29: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 30: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Pharmaceutical by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 32: World Historic Review for Pharmaceutical by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 33: World 15-Year Perspective for Pharmaceutical by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 34: World Current & Future Analysis for Nutraceutical by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 35: World Historic Review for Nutraceutical by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR

Table 36: World 15-Year Perspective for Nutraceutical by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 37: World Current & Future Analysis for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR

Table 38: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 39: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 40: USA Current & Future Analysis for Empty Capsules by
Product - Gelatin and Non-Gelatin - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 41: USA Historic Review for Empty Capsules by Product -
Gelatin and Non-Gelatin Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 42: USA 15-Year Perspective for Empty Capsules by Product -
Percentage Breakdown of Value Sales for Gelatin and
Non-Gelatin for the Years 2012, 2020 & 2027

Table 43: USA Current & Future Analysis for Empty Capsules by
Functionality - Immediate-Release Capsules, Sustained-Release
Capsules and Delayed-Release Capsules - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 44: USA Historic Review for Empty Capsules by
Functionality - Immediate-Release Capsules, Sustained-Release
Capsules and Delayed-Release Capsules Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 45: USA 15-Year Perspective for Empty Capsules by
Functionality - Percentage Breakdown of Value Sales for
Immediate-Release Capsules, Sustained-Release Capsules and
Delayed-Release Capsules for the Years 2012, 2020 & 2027

Table 46: USA Current & Future Analysis for Empty Capsules by
Application - Antibiotics, Vitamins and Dietary Supplements,
Antacid & Antiflatulent Preparations and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 47: USA Historic Review for Empty Capsules by Application -
Antibiotics, Vitamins and Dietary Supplements, Antacid &
Antiflatulent Preparations and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 48: USA 15-Year Perspective for Empty Capsules by
Application - Percentage Breakdown of Value Sales for
Antibiotics, Vitamins and Dietary Supplements, Antacid &
Antiflatulent Preparations and Other Applications for the Years
2012, 2020 & 2027

Table 49: USA Current & Future Analysis for Empty Capsules by
End-Use - Pharmaceutical, Nutraceutical and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 50: USA Historic Review for Empty Capsules by End-Use -
Pharmaceutical, Nutraceutical and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 51: USA 15-Year Perspective for Empty Capsules by End-Use -
Percentage Breakdown of Value Sales for Pharmaceutical,
Nutraceutical and Other End-Uses for the Years 2012, 2020 &
2027

CANADA
Table 52: Canada Current & Future Analysis for Empty Capsules
by Product - Gelatin and Non-Gelatin - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 53: Canada Historic Review for Empty Capsules by Product -
Gelatin and Non-Gelatin Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 54: Canada 15-Year Perspective for Empty Capsules by
Product - Percentage Breakdown of Value Sales for Gelatin and
Non-Gelatin for the Years 2012, 2020 & 2027

Table 55: Canada Current & Future Analysis for Empty Capsules
by Functionality - Immediate-Release Capsules,
Sustained-Release Capsules and Delayed-Release Capsules -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 56: Canada Historic Review for Empty Capsules by
Functionality - Immediate-Release Capsules, Sustained-Release
Capsules and Delayed-Release Capsules Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 57: Canada 15-Year Perspective for Empty Capsules by
Functionality - Percentage Breakdown of Value Sales for
Immediate-Release Capsules, Sustained-Release Capsules and
Delayed-Release Capsules for the Years 2012, 2020 & 2027

Table 58: Canada Current & Future Analysis for Empty Capsules
by Application - Antibiotics, Vitamins and Dietary Supplements,
Antacid & Antiflatulent Preparations and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 59: Canada Historic Review for Empty Capsules by
Application - Antibiotics, Vitamins and Dietary Supplements,
Antacid & Antiflatulent Preparations and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 60: Canada 15-Year Perspective for Empty Capsules by
Application - Percentage Breakdown of Value Sales for
Antibiotics, Vitamins and Dietary Supplements, Antacid &
Antiflatulent Preparations and Other Applications for the Years
2012, 2020 & 2027

Table 61: Canada Current & Future Analysis for Empty Capsules
by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 62: Canada Historic Review for Empty Capsules by End-Use -
Pharmaceutical, Nutraceutical and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 63: Canada 15-Year Perspective for Empty Capsules by
End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical, Nutraceutical and Other End-Uses for the Years
2012, 2020 & 2027

JAPAN
Table 64: Japan Current & Future Analysis for Empty Capsules by
Product - Gelatin and Non-Gelatin - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 65: Japan Historic Review for Empty Capsules by Product -
Gelatin and Non-Gelatin Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 66: Japan 15-Year Perspective for Empty Capsules by
Product - Percentage Breakdown of Value Sales for Gelatin and
Non-Gelatin for the Years 2012, 2020 & 2027

Table 67: Japan Current & Future Analysis for Empty Capsules by
Functionality - Immediate-Release Capsules, Sustained-Release
Capsules and Delayed-Release Capsules - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 68: Japan Historic Review for Empty Capsules by
Functionality - Immediate-Release Capsules, Sustained-Release
Capsules and Delayed-Release Capsules Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 69: Japan 15-Year Perspective for Empty Capsules by
Functionality - Percentage Breakdown of Value Sales for
Immediate-Release Capsules, Sustained-Release Capsules and
Delayed-Release Capsules for the Years 2012, 2020 & 2027

Table 70: Japan Current & Future Analysis for Empty Capsules by
Application - Antibiotics, Vitamins and Dietary Supplements,
Antacid & Antiflatulent Preparations and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 71: Japan Historic Review for Empty Capsules by
Application - Antibiotics, Vitamins and Dietary Supplements,
Antacid & Antiflatulent Preparations and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 72: Japan 15-Year Perspective for Empty Capsules by
Application - Percentage Breakdown of Value Sales for
Antibiotics, Vitamins and Dietary Supplements, Antacid &
Antiflatulent Preparations and Other Applications for the Years
2012, 2020 & 2027

Table 73: Japan Current & Future Analysis for Empty Capsules by
End-Use - Pharmaceutical, Nutraceutical and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 74: Japan Historic Review for Empty Capsules by End-Use -
Pharmaceutical, Nutraceutical and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 75: Japan 15-Year Perspective for Empty Capsules by
End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical, Nutraceutical and Other End-Uses for the Years
2012, 2020 & 2027

CHINA
Table 76: China Current & Future Analysis for Empty Capsules by
Product - Gelatin and Non-Gelatin - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 77: China Historic Review for Empty Capsules by Product -
Gelatin and Non-Gelatin Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 78: China 15-Year Perspective for Empty Capsules by
Product - Percentage Breakdown of Value Sales for Gelatin and
Non-Gelatin for the Years 2012, 2020 & 2027

Table 79: China Current & Future Analysis for Empty Capsules by
Functionality - Immediate-Release Capsules, Sustained-Release
Capsules and Delayed-Release Capsules - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 80: China Historic Review for Empty Capsules by
Functionality - Immediate-Release Capsules, Sustained-Release
Capsules and Delayed-Release Capsules Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 81: China 15-Year Perspective for Empty Capsules by
Functionality - Percentage Breakdown of Value Sales for
Immediate-Release Capsules, Sustained-Release Capsules and
Delayed-Release Capsules for the Years 2012, 2020 & 2027

Table 82: China Current & Future Analysis for Empty Capsules by
Application - Antibiotics, Vitamins and Dietary Supplements,
Antacid & Antiflatulent Preparations and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 83: China Historic Review for Empty Capsules by
Application - Antibiotics, Vitamins and Dietary Supplements,
Antacid & Antiflatulent Preparations and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 84: China 15-Year Perspective for Empty Capsules by
Application - Percentage Breakdown of Value Sales for
Antibiotics, Vitamins and Dietary Supplements, Antacid &
Antiflatulent Preparations and Other Applications for the Years
2012, 2020 & 2027

Table 85: China Current & Future Analysis for Empty Capsules by
End-Use - Pharmaceutical, Nutraceutical and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 86: China Historic Review for Empty Capsules by End-Use -
Pharmaceutical, Nutraceutical and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 87: China 15-Year Perspective for Empty Capsules by
End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical, Nutraceutical and Other End-Uses for the Years
2012, 2020 & 2027

EUROPE
Table 88: Europe Current & Future Analysis for Empty Capsules
by Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 89: Europe Historic Review for Empty Capsules by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 90: Europe 15-Year Perspective for Empty Capsules by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2020 & 2027

Table 91: Europe Current & Future Analysis for Empty Capsules
by Product - Gelatin and Non-Gelatin - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 92: Europe Historic Review for Empty Capsules by Product -
Gelatin and Non-Gelatin Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 93: Europe 15-Year Perspective for Empty Capsules by
Product - Percentage Breakdown of Value Sales for Gelatin and
Non-Gelatin for the Years 2012, 2020 & 2027

Table 94: Europe Current & Future Analysis for Empty Capsules
by Functionality - Immediate-Release Capsules,
Sustained-Release Capsules and Delayed-Release Capsules -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 95: Europe Historic Review for Empty Capsules by
Functionality - Immediate-Release Capsules, Sustained-Release
Capsules and Delayed-Release Capsules Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 96: Europe 15-Year Perspective for Empty Capsules by
Functionality - Percentage Breakdown of Value Sales for
Immediate-Release Capsules, Sustained-Release Capsules and
Delayed-Release Capsules for the Years 2012, 2020 & 2027

Table 97: Europe Current & Future Analysis for Empty Capsules
by Application - Antibiotics, Vitamins and Dietary Supplements,
Antacid & Antiflatulent Preparations and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 98: Europe Historic Review for Empty Capsules by
Application - Antibiotics, Vitamins and Dietary Supplements,
Antacid & Antiflatulent Preparations and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 99: Europe 15-Year Perspective for Empty Capsules by
Application - Percentage Breakdown of Value Sales for
Antibiotics, Vitamins and Dietary Supplements, Antacid &
Antiflatulent Preparations and Other Applications for the Years
2012, 2020 & 2027

Table 100: Europe Current & Future Analysis for Empty Capsules
by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 101: Europe Historic Review for Empty Capsules by End-Use -
Pharmaceutical, Nutraceutical and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 102: Europe 15-Year Perspective for Empty Capsules by
End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical, Nutraceutical and Other End-Uses for the Years
2012, 2020 & 2027

FRANCE
Table 103: France Current & Future Analysis for Empty Capsules
by Product - Gelatin and Non-Gelatin - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 104: France Historic Review for Empty Capsules by Product -
Gelatin and Non-Gelatin Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 105: France 15-Year Perspective for Empty Capsules by
Product - Percentage Breakdown of Value Sales for Gelatin and
Non-Gelatin for the Years 2012, 2020 & 2027

Table 106: France Current & Future Analysis for Empty Capsules
by Functionality - Immediate-Release Capsules,
Sustained-Release Capsules and Delayed-Release Capsules -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 107: France Historic Review for Empty Capsules by
Functionality - Immediate-Release Capsules, Sustained-Release
Capsules and Delayed-Release Capsules Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 108: France 15-Year Perspective for Empty Capsules by
Functionality - Percentage Breakdown of Value Sales for
Immediate-Release Capsules, Sustained-Release Capsules and
Delayed-Release Capsules for the Years 2012, 2020 & 2027

Table 109: France Current & Future Analysis for Empty Capsules
by Application - Antibiotics, Vitamins and Dietary Supplements,
Antacid & Antiflatulent Preparations and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 110: France Historic Review for Empty Capsules by
Application - Antibiotics, Vitamins and Dietary Supplements,
Antacid & Antiflatulent Preparations and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 111: France 15-Year Perspective for Empty Capsules by
Application - Percentage Breakdown of Value Sales for
Antibiotics, Vitamins and Dietary Supplements, Antacid &
Antiflatulent Preparations and Other Applications for the Years
2012, 2020 & 2027

Table 112: France Current & Future Analysis for Empty Capsules
by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 113: France Historic Review for Empty Capsules by End-Use -
Pharmaceutical, Nutraceutical and Other End-Uses Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 114: France 15-Year Perspective for Empty Capsules by
End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical, Nutraceutical and Other End-Uses for the Years
2012, 2020 & 2027

GERMANY
Table 115: Germany Current & Future Analysis for Empty Capsules
by Product - Gelatin and Non-Gelatin - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 116: Germany Historic Review for Empty Capsules by
Product - Gelatin and Non-Gelatin Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 117: Germany 15-Year Perspective for Empty Capsules by
Product - Percentage Breakdown of Value Sales for Gelatin and
Non-Gelatin for the Years 2012, 2020 & 2027

Table 118: Germany Current & Future Analysis for Empty Capsules
by Functionality - Immediate-Release Capsules,
Sustained-Release Capsules and Delayed-Release Capsules -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 119: Germany Historic Review for Empty Capsules by
Functionality - Immediate-Release Capsules, Sustained-Release
Capsules and Delayed-Release Capsules Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR

Table 120: Germany 15-Year Perspective for Empty Capsules by
Functionality - Percentage Breakdown of Value Sales for
Immediate-Release Capsules, Sustained-Release Capsules and
Delayed-Release Capsules for the Years 2012, 2020 & 2027

Table 121: Germany Current & Future Analysis for Empty Capsules
by Application - Antibiotics, Vitamins and Dietary Supplements,
Antacid & Antiflatulent Preparations and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 122: Germany Historic Review for Empty Capsules by
Application - Antibiotics, Vitamins and Dietary Supplements,
Antacid & Antiflatulent Preparations and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 123: Germany 15-Year Perspective for Empty Capsules by
Application - Percentage Breakdown of Value Sales for
Antibiotics, Vitamins and Dietary Supplements, Antacid &
Antiflatulent Preparations and Other Applications for the Years
2012, 2020 & 2027

Table 124: Germany Current & Future Analysis for Empty Capsules
by End-Use - Pharmaceutical, Nutraceutical and Other End-Uses -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Table 125: Germany Historic Review for Empty Capsules by
End-Use - Pharmaceutical, Nutraceutical and Other End-Uses
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 126: Germany 15-Year Perspective for Empty Capsules by
End-Use - Percentage Breakdown of Value Sales for
Pharmaceutical, Nutraceutical and Other End-Uses for the Years
2012, 2020 & 2027

ITALY
Table 127: Italy Current & Future Analysis for Empty Capsules
by Product - Gelatin and Non-Gelatin - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 128: Italy Historic Review for Empty Capsules by Product -
Gelatin and Non-Gelatin Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2012 through 2019 and %
CAGR

Table 129: Italy 15-Year Perspective for Empty Capsules by
Product - Percentage Breakdown of Value Sales for Gelatin and
Non-Gelatin for the Years 2012, 2020 & 2027

Table 130: Italy Current & Future Analysis for Empty Capsules
by Functionality - Immediate-Release Capsules,
Sustained-Release Capsules and Delayed-Release Capsules -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06041104/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001